In this cohort, the immunoregulatory pathway TGF-β/SMAD is modulated by miR-26b-5p and the impairment of this axis bypasses cell cycle arrest in CLL cells facilitating disease progression. This evidence concerns the gene TGFB1 and B-cell chronic lymphocytic leukemia.